openPR Logo
Press release

Biological Drugs Market to Rise due to Advancements in Biomedical Science

Biological Drugs Market to Rise due to Advancements

Biological drugs have been utilized for the treatment and prevention of a number of diseases such as blood disorders, cancers, and auto-immune diseases. These drugs are derived via living cells and have structures that are more complicated as compared to that of traditional drugs. In addition, biological drugs market are more difficult to develop and categorize and are highly sensitive in nature. A typical biological drug involves approximately 250 in-process tests while it is manufactured, in comparison to the approximately 50 tests involved in the manufacturing of a typical traditional drug.

Interested in report: Please follow the below links to meet your requirements;
Request for the Report Brochure: http://www.persistencemarketresearch.com/samples/2883

Rising Occurrence of Chronic Diseases to Boost Biological Drugs Market

The development of the field of biomedical science exhibits great potential for the development of the market for biological drugs. In addition, factors such as the rising aging population and the rising occurrence of chronic diseases have also stimulated the biological drugs market. Furthermore, a number of government organizations globally have also been taking steps favoring the usage of biological drugs, hence boosting the market. On the other hand, factors such as the soaring costs of biological drugs as well as the patent expiry of blockbuster drugs may restrain the growth of the market. In addition, the increasing risk of side-effects with the usage of biologic injectable drugs may also impede the growth of the market in forthcoming years.

Enbrel Therapeutic Protein and Prevnar 13 Vaccine Held the Largest Shares in 2014

On the basis of therapeutic protein, the market for biological drugs is segmented into Neulasta, Enbrel, Lantus, Rebif, Avonex, NovoLog, Neupogen, Eylea, Betaseron, Epogen, Levemir, Humalog, and Aranesp. Amongst these, the segment of Enbrel leads the market for biological drugs and is the most swiftly developing segment of the market. In terms of monoclonal antibody (mAb), the market is segmented into Rituxan, Avastin, Remicade, Herceptin, Humira, and Lucentis. Amongst these, the segment of Humira emerged as the most rapidly growing mAb segment of the market. Among vaccines, the market for biological drugs is segmented into Varivax, Ceravix, Fluzone, Prevnar 13, and Gardasil. Amongst these, the segment of Prevnar 13 emerged as the most swiftly growing and the largest segment of the market.

North America Biological Drugs Market to Lead with a 10.90 % CAGR till 2020

Request TOC (table of content), Figures and Tables of the Report: http://www.persistencemarketresearch.com/toc/2883

Geographically, the market is segmented into North America, Europe, Asia Pacific, and Rest of the World (RoW). Amongst these, North America holds the largest share in the market and is followed by Europe. The region of North America is predicted to expand at a 10.90% CAGR from 2014 to 2020. The reason for the dominance of the regional market of North America is the rising usage of biological products in the treatment of diseases such as diabetes, cancer, and many other life-threatening conditions. Furthermore, the supportive steps taken by the North American government have also fuelled the market for biological drugs in this region. On the other hand, the growing geriatric population suffering from number of ailments such as glaucoma and macular degeneration within Europe has also augmented the development of the biological drugs market in this region.

The chief vendors prevalent in the biological drugs market are Roche, Amgen, and Novo Nordisk. Other notable companies in the market are Abbott Laboratories, Pfizer, Novartis, Eli Lilly, Bristol-Myers Squibb, Biogen, and Baxter, among others.

About Us

Persistence Market Research (PMR) is a full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.

Contact

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States
USA - Canada Toll Free: +1 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biological Drugs Market to Rise due to Advancements in Biomedical Science here

News-ID: 341251 • Views:

More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Persistence Market Research
Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by Sustainability and Supply Chain Efficiency
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Growth - Persistence Market Research
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Healthcare Demand
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained

All 5 Releases


More Releases for Biological

Biological Control Market Projected to Witness Massive Growth - Koppert Biologic …
Biological Control Market Snapshot The Biological Control Market is projected to reach USD 9.7 billion by 2032, growing at a CAGR of 9.4% from 2025 to 2032. Coherent Market Insights proudly presents its latest Biological Control Market Research Report, delivering a detailed examination of the U.S. Biological Control Market outlook from 2025 to 2032. This comprehensive analysis provides strategic forecasts at both national and regional levels, addressing evolving supply networks, payer-provider collaboration,
Biological and Chemical Indicators Market - Beyond Measure: Biological and Chemi …
Newark, New Castle, USA: The "Biological and Chemical Indicators Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Biological and Chemical Indicators Market: https://www.growthplusreports.com/report/biological-and-chemical-indicators-market/8887 This latest report researches the
Biological APIs Market - Biological APIs: The Driving Force Behind Cutting-Edge …
Newark, New Castle, USA: The "Biological APIs Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Biological APIs Market: https://www.growthplusreports.com/report/biological-apis-market/8769 This latest report researches the industry structure, sales, revenue,
Human Immunoglobulin for Intravenous Injection Market demand and future scope wi …
A recent market research report added to repository of MR Accuracy Reports is an in-depth analysis of global Human Immunoglobulin for Intravenous Injection. On the basis of historic growth analysis and current scenario of Human Immunoglobulin for Intravenous Injection place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from
Global Biological safety testing Market | Global Biological safety testing Indus …
Biologics are termed as those product that attained from living organism and feature a differentiate set of properties. The biologics want extreme safety from contamination thus biological safety testing is incorporate timely to make sure its safety quality and non-contamination of vaccines & biopharmaceuticals, along with comply with the bound rules applicable on it. A number of the foremost biological tests are sterility testing, bioburden testing, residual host contaminant detection
Meningococcal Infections Vaccine Market Insights, Forecast to 2025 : Sanofi-Past …
Researchmoz added Most up-to-date research on "Global Meningococcal Infections Vaccine Market Insights, Forecast to 2025" to its huge collection of research reports. This report studies the global market size of Meningococcal Infections Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Meningococcal Infections Vaccine in these regions. This research report categorizes the global Meningococcal Infections Vaccine market